-
Product Insights
Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) - Drugs In Development, 2024
Empower your strategies with our Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) – Drugs In Development, 2024 report and make more profitable business decisions. Kawasaki disease, or mucocutaneous lymph node syndrome, is a rare illness that mainly affects children under the age of 5. Symptoms include swollen glands in the neck; dry, red cracked lips; strawberry tongue; and swelling of the mucous membranes inside the mouth, nose, eyes, and throat. Diagnostic criteria include prolonged fever for more than five days and generally...
-
Product Insights
Granulomatosis with Polyangiitis (Wegener's Granulomatosis) - Drugs In Development, 2024
Empower your strategies with our Granulomatosis with Polyangiitis (Wegener's Granulomatosis) – Drugs In Development, 2024 report and make more profitable business decisions. Wegener polyangiitis is an uncommon disorder that causes inflammation of blood vessels. This inflammation restricts blood flow to various organs. Signs and symptoms include constantly runny nose, nose bleeds, ear infections, cough, chest pain, skin sores, and fever. Predisposing factors include age. Treatment includes immunosuppressants and corticosteroids. The Granulomatosis with Polyangiitis (Wegener's Granulomatosis) drugs in development market research report...
-
Product Insights
Lung Transplant Rejection - Drugs In Development, 2024
Empower your strategies with our Lung Transplant Rejection – Drugs In Development, 2024 report and make more profitable business decisions. Lung transplantation is the therapy used in various lung diseases. A lung transplant replaces an injured or diseased lung with a healthy one. Risk factors associated with transplantation are bleeding, infection, clots, and cardiovascular disorders. Following a transplant, the immune system may consider the transplanted lung as foreign and may work against it. Patients may hence develop complications and eventually reject...
-
Product Insights
House Dust Mite Allergy - Drugs In Development, 2024
Empower your strategies with our House Dust Mite Allergy – Drugs In Development, 2024 report and make more profitable business decisions. House dust mite allergy is an allergic reaction to tiny bugs that commonly live in house dust. Symptoms include frequent sneezing, a runny, stuffy, itchy nose, and irritated eyes. Asthma and eczema can also be triggered by a dust mite allergy. Symptoms often worsen when the individual comes in close proximity to disturbed dust. The predisposing factors include family history...
-
Product Insights
Pemphigus Vulgaris - Drugs In Development, 2024
Empower your strategies with our Pemphigus Vulgaris – Drugs In Development, 2024 report and make more profitable business decisions. Pemphigus vulgaris is a rare autoimmune disease that causes painful blistering on the skin and the mucous membranes. Risk factors include race, gender, and age. Symptoms of pemphigus vulgaris include painful blisters that start in the mouth, and skin blisters that come and go. The blisters always occur near the surface of the skin and there is oozing, crusting, or peeling at...
-
Product Insights
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) - Drugs In Development, 2024
Empower your strategies with our Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) – Drugs In Development, 2024 report and make more profitable business decisions. Chronic Cutaneous Lupus Erythematosus also known as discoid lupus is a group of autoimmune disorders affecting the major areas of skin that can be associated with SLE. CLE is classified as acute, subacute, intermittent, and chronic. Although the cause is unknown major concerns are genetic, innate, and adaptive immune responses, smoking, exposure to sun,...
-
Product Insights
Grass Pollen Allergy - Drugs In Development, 2024
Empower your strategies with our Grass Pollen Allergy – Drugs In Development, 2024 report and make more profitable business decisions. Grass pollen allergy is a reaction which occurs soon after exposure to pollen from grasses. Signs and symptoms include skin reactions such as hives, redness, or swelling; itching or tingling in or around the mouth and throat; tightening of the throat; shortness of breath or wheezing; and runny nose. Predisposing factors include age, family history, and other allergies. The Grass Pollen...
-
Product Insights
Liver Transplant Rejection - Drugs In Development, 2024
Empower your strategies with our Liver Transplant Rejection – Drugs In Development, 2024 report and make more profitable business decisions. Liver transplantation is the conventional therapy used in various liver diseases. The liver has the unique ability to regenerate or regrow. Liver transplantation replaces an injured or diseased liver with a healthy one; an entire liver or just a section may be transplanted. Following a transplant, the immune system may consider the transplanted liver as foreign and may work against it....
-
Product Insights
Primary Sjogren's Syndrome - Drugs In Development, 2024
Empower your strategies with our Primary Sjogren's Syndrome – Drugs In Development, 2024 report and make more profitable business decisions. Primary Sjogren's Syndrome is a common chronic autoimmune disorder that affects the lacrimal and salivary glands, and some may develop extra glandular involvement of joints, GI tract, lungs, skin, CNS, and kidneys. Dry eyes and dryness of mouth are characteristic features of this condition. Joint pain, skin rashes, and dry cough are some other symptoms. Eye drops treat dry eyes which...
-
Product Insights
Pulmonary Sarcoidosis - Drugs In Development, 2024
Empower your strategies with our Pulmonary Sarcoidosis – Drugs In Development, 2024 report and make more profitable business decisions. Pulmonary Sarcoidosis is a rare inflammatory disease that affects the multi-organs predominantly lungs and intrathoracic lymph nodes. It is characterized by the presence of granulomas in which group of cells form clusters of inflamed tissue. Younger and middle-aged groups are commonly affected and there is no specific origin causing this condition. It is differentiated into five different stages from stage 0 to...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.